Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias

The paradigm for the treatment of monoclonal gammopaties has dramatically changed: therapeutic options in multiple myeloma (MM) have evolved from the introduction of melphalan and prednisone in the 1960s, high-dose chemotherapy and stem cell transplantation in the late 1980s and 1990s, to the rapid...

Descripción completa

Detalles Bibliográficos
Autores principales: Roccaro, Aldo M, Ghobrial, Irene M, Blotta, Simona, Treon, Steven P, Malagola, Michele, Anderson, Kenneth C, Richardson, Paul G, Russo, Domenico
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721375/
https://www.ncbi.nlm.nih.gov/pubmed/19707373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721375/
https://www.ncbi.nlm.nih.gov/pubmed/19707373

Ejemplares similares